Back to search

Article

Use of SGLT-2 inhibitors in pediatric heart failure: a multi-center study

2025-05-16

Abstract excerpt

<title>Abstract</title> <p>Introduction: There has been a rapid adoption of SGLT2i in pediatric heart failure despite a lack of evidence. To better understand the utilization and safety profile of SGLT2i, we collected data from patients treated at pediatric heart centers with SGLT2i. <h4>Methods:</h4> A multicenter retrospective study was performed utilizing ACTION’s pediatric heart failure registry. Patient demo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fbd4a0c0-e61e-5e6a-860d-a8a2d06a56a3
DOI
10.21203/rs.3.rs-6649594/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Use of SGLT-2 inhibitors in pediatric heart failure: a multi-center studyDOI 10.21203/rs.3.rs-6649594/v1
Efficacy and safety of SGLT2 inhibitors in the treatment of heart failure-May raise creatinine levels in patients: A meta-analysisSemantic proximity
Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.Semantic proximity
Phenotype of Children with QT Prolongation Identified Using an Institution-Wide QT Alert System.Semantic proximity
SGLT2i, ARNi and Diuretic Use in Patients with Heart Failure Among the Preserved and Reduced Ejection Fraction: A Retrospective Observational StudySemantic proximity
Patients with Congenital Heart Disease Have Inferior Intent-to-Treat Outcomes When Listed for Pediatric Heart TransplantationSemantic proximity
Pediatric Beta Blocker Therapy: A Comprehensive Review of Development and Genetic Variation to Guide Precision-Based Therapy in Children, Adolescents, and Young Adults.Semantic proximity
Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry.Semantic proximity
Real-World Effectiveness of SGLT2 Inhibitors Across Heart Failure Phenotypes: A Meta-Analysis.Semantic proximity
Left Ventricular Assist Device Implantation in Pediatric Duchenne Muscular Dystrophy with Advanced Heart Failure: A Single-Center StudySemantic proximity
Cystic Fibrosis Foundation Practice Guidelines for the Management of Infants with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome during the First Two Years of Life and BeyondSemantic proximity
Harnessing the Synergy of SGLT2 Inhibitors and Continuous Ketone Monitoring (CKM) in Managing Heart Failure Among Patients with Type 1 DiabetesSemantic proximity
Development of SGLT1 and SGLT2 inhibitors.Semantic proximity
Select a neighboring publication to make it the new centre.